Share buybacks often indicate management’s confidence in a company’s prospects and can enhance shareholder value by reducing the number of outstanding shares.
Several listed companies have recently announced buyback programmes through the tender offer route. Among them are Wipro, Zydus Lifesciences, Aurobindo Pharma, Cyient, and CMS Info Systems.
Here’s a look at the key details.
1. Wipro Limited
With a market capitalisation of ₹1.92 lakh crore, Wipro shares closed at ₹182.95, up 0.85% from the previous close of ₹181.40.
Buyback details
- Buyback size: ₹15,000 crore
- Maximum buyback price: ₹250 per share
- Record date: June 5, 2026
- Tendering period: June 11 to June 17, 2026
Q4 FY26 performance
- Revenue: ₹24,236 crore (up 7.7%)
- Net profit: ₹3,522 crore (down 1.84%)
Key ratios
- ROCE: 17.9%
- ROE: 15.5%
- EPS: ₹12.6
- Debt-to-equity ratio: 0.23
Founded in 1945, Wipro provides IT, consulting and business process services and serves customers in more than 65 countries.
2. Zydus Lifesciences Limited
Zydus Lifesciences has a market capitalisation of ₹1.08 lakh crore. The stock ended at ₹1,080.25, down 0.69%.
Buyback details
- Buyback size: ₹1,100 crore
- Maximum buyback price: ₹1,260 per share
- Record date: May 29, 2026
- Tendering period: June 4 to June 10, 2026
Q4 FY26 performance
- Revenue: ₹7,587 crore (up 16.22%)
- Net profit: ₹1,341 crore (up 7.79%)
Key ratios
- ROCE: 21.2%
- ROE: 21.2%
- EPS: ₹50.1
- Debt-to-equity ratio: 0.46
Formerly known as Cadila Healthcare, the Ahmedabad-based company operates in more than 50 countries.
3. Aurobindo Pharma Limited
Shares of Aurobindo Pharma closed at ₹1,393.95, down 0.93%. The company has a market capitalisation of ₹80,960.84 crore.
Buyback details
- Buyback size: ₹800 crore
- Maximum buyback price: ₹1,475 per share
- Record date: April 17, 2026
- Tendering period: April 23 to April 29, 2026
Q4 FY26 performance
- Revenue: ₹8,853 crore (up 5.62%)
- Net profit: ₹921 crore (up 1.99%)
Key ratios
- ROCE: 12.8%
- ROE: 10.1%
- EPS: ₹60.3
- Debt-to-equity ratio: 0.21
The Hyderabad-based drugmaker operates in more than 150 countries.
4. Cyient Limited
Cyient shares closed at ₹906.25, up 1.03%. The company commands a market capitalisation of ₹10,072.23 crore.
Buyback details
- Buyback size: ₹720 crore
- Maximum buyback price: ₹1,125 per share
- Record date: June 17, 2026
- Opening and closing dates: Yet to be announced
Q4 FY26 performance
- Revenue: ₹1,927 crore (up 0.94%)
- Net profit: ₹66 crore (down 64.52%)
Key ratios
- ROCE: 12.3%
- ROE: 8.61%
- EPS: ₹38.5
- Debt-to-equity ratio: 0.08
Cyient provides engineering, digital and geospatial services to global customers.
5. CMS Info Systems Limited
CMS Info Systems shares settled at ₹295.25, down 1.06%. The company has a market capitalisation of ₹4,860.92 crore.
Buyback details
- Buyback size: ₹167 crore
- Maximum buyback price: ₹340 per share
- Record date: May 22, 2026
- Tendering period: May 29 to June 4, 2026
Q4 FY26 performance
- Revenue: ₹633 crore (up 2.29%)
- Net profit: ₹79 crore (down 19.39%)
Key ratios
- ROCE: 17.6%
- ROE: 13.2%
- EPS: ₹18.4
- Debt-to-equity ratio: 0.09
CMS Info Systems is one of India’s largest cash logistics and business services companies.
Buyback details at a glance
| Company | Buyback Size | Maximum Price |
|---|---|---|
| Wipro | ₹15,000 crore | ₹250 |
| Zydus Lifesciences | ₹1,100 crore | ₹1,260 |
| Aurobindo Pharma | ₹800 crore | ₹1,475 |
| Cyient | ₹720 crore | ₹1,125 |
| CMS Info Systems | ₹167 crore | ₹340 |
TL;DR
Wipro, Zydus Lifesciences, Aurobindo Pharma, Cyient and CMS Info Systems have recently announced buyback offers. Wipro’s ₹15,000 crore programme is the largest among the five companies.
AI Summary
- Five companies have announced buybacks through the tender offer route.
- Wipro’s ₹15,000 crore buyback is the biggest.
- Zydus Lifesciences has proposed a ₹1,100 crore buyback.
- Cyient’s offer dates are yet to be announced.
- All five companies maintain low debt levels.
